Abstract
Stem cell therapy promises to open exciting new options in the treatment of cardiovascular diseases. Although feasible and clinically safe, the in vivo behavior and integration of stem cell transplants still remain largely unknown. Thus, the development of innovative non-invasive imaging techniques capable of effectively tracking such therapy in vivo is vital for a more in-depth investigation into future clinical applications. Such imaging modalities will not only generate further insight into the mechanisms behind stem cell-based therapy, but also address some major concerns associated with translational cardiovascular stem cell therapy. In the present review, we summarize the principles underlying three major stem cell tracking methods: (1) radioactive labeling for positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging, (2) iron particle labeling for magnetic resonance imaging (MRI), and (3) reporter gene labeling for bioluminescence, fluorescence, MRI, SPECT, and PET imaging. We then discuss recent clinical studies that have utilized these modalities to gain biological insights into stem cell fate.
Similar content being viewed by others
References
Capewell, S., Ford, E.S., Croft, J.B., et al. (2010). Cardiovascular risk factor trends and potentials for reducing coronary heart disease mortality in the United States of America. Bulletin World Health Organization, 88(2), 120–30.
Gong, Z., & Niklason, L. E. (2011). Use of human mesenchymal stem cells as alternative source of smooth muscle cells in vessel engineering. Methods in Molecular Biology, 698, 279–294.
Mignone, J. L., Kreutziger, K. L., Paige, S. L., et al. (2010). Cardiogenesis from human embryonic stem cells. Circulation Journal, 74(12), 2517–2526.
Schuster, M. D., Kocher, A. A., Seki, T., et al. (2004). Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. American Journal of Physiology. Heart and Circulatory Physiology, 287, H525–H532.
Li, Z., Lee, A., Huang, M., et al. (2009). Imaging survival and function of transplanted cardiac resident stem cells. Journal of the American College of Cardiology, 53(14), 1229–1240.
Li, Z., Wilson, K. D., Smith, B., et al. (2009). Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS ONE, 4(12), e8443.
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicines, 7, 430–436.
Cho, J., Zhai, P., Maejima, Y., et al. (2011). Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circulation Research, 108(4), 478–489.
Phelps, M. E. (2000). Positron emission tomography provides molecular imaging of biological processes. Proceedings of the National Academy of Sciences of the United States of America, 97(16), 9226–9233.
Correa, P. L., Mesquita, C. T., Felix, R. M., et al. (2007). Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clinical Nuclear Medicine, 32(11), 839–841.
Aicher, A., Brenner, W., Zuhayra, M., et al. (2003). Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation, 107, 2134–2139.
van der Spoel, T. I., Lee, J. C., Vrijsen, K., et al. (2010). Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. The International Journal of Cardiovascular Imaging. doi:10.1007/s10554-010-9658-4.
Massoud, T. F., & Gambhir, S. S. (2003). Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes & Development, 17, 545–580.
Bulte, J. W. (2009). In vivo MRI cell tracking: clinical studies. American Journal of Roentgenology, 193(2), 314–325.
Bulte, J. W., & Kraitchman, D. L. (2004). Iron oxide MR contrast agents for molecular and cellular imaging. NMR in Biomedicine, 17, 484–499.
Modo, M., Mellodew, K., Cash, D., et al. (2004). Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage, 21, 311–317.
Anderson, S. A., Lee, K. K., & Frank, J. A. (2006). Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Investigative Radiology, 41, 332–338.
Li, Z., Suzuki, Y., Huang, M., et al. (2008). Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells, 26(4), 864–873.
Wu, J. C., Tseng, J. R., & Gambhir, S. S. (2004). Molecular imaging of cardiovascular gene products. Journal of Nuclear Cardiology, 11(4), 491–505.
Swijnenburg, R. J., Schrepfer, S., Govaert, J. A., et al. (2008). Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proceedings of the National Academy of Sciences of the United States of America, 105(35), 12991–12996.
Cao, F., Lin, S., Xie, X., et al. (2006). In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation, 113, 1005–1014.
van der Bogt, K. E., Sheikh, A. Y., Schrepfer, S., et al. (2008). Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation, 118(14 Suppl), S121–S129.
Li, Z., Wu, J. C., Sheikh, A. Y., et al. (2007). Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation, 116, I46–I54.
Lee, A. S., Tang, C., Cao, F., et al. (2009). Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle, 8(16), 2608–2612.
Cao, F., Wagner, R. A., Wilson, K. D., et al. (2008). Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS ONE, 3(10), e3474.
Gyöngyösi, M. B. J., Marian, T., Tron, L., et al. (2008). Serial non-invasive in vivo positron emission tomographic (PET) tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circulation Cardiovasc Imag, 1, 94–103.
Willmann, J. K., Paulmurugan, R., Rodriguez-Porcel, M., et al. (2009). Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology, 252, 117–127.
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415–419.
Thyagarajan, B., Liu, Y., Shin, S., et al. (2008). Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells, 26(1), 119–126.
Chen, I. Y., & Wu, J. C. (2011). Cardiovascular molecular imaging: focus on clinical translation. Circulation, 123, 425–443.
Hofmann, M., Wollert, K. C., Meyer, G. P., et al. (2005). Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation, 111(17), 2198–2202.
Karpov, R. S., Popov, S. V., Markov, V. A., et al. (2005). Autologous mononuclear bone marrow cells during reparative regeneration after acute myocardial infarction. Bulletin of Experimental Biology and Medicine, 140(5), 640–643.
Kang, W. J., Kang, H. J., Kim, H. S., et al. (2006). Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. Journal of Nuclear Medicine, 47(8), 1295–1301.
Goussetis, E., Manginas, A., Koutelou, M., et al. (2006). Intracoronary infusion of CD133+ and CD133−CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells, 24(10), 2279–2283.
Blocklet, D., Toungouz, M., Berkenboom, G., et al. (2006). Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells, 24(2), 333–336.
Penicka, M., Lang, O., Widimsky, P., et al. (2007). One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction. Heart, 93(7), 837–841.
Schächinger, V., Aicher, A., Döbert, N., et al. (2008). Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation, 18(14), 1425–1432.
Dedobbeleer, C., Blocklet, D., Toungouz, M., et al. (2009). Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction. Journal of Cardiovascular Pharmacology, 53(6), 480–485.
de Vries, I. J., Lesterhuis, W. J., Barentsz, J. O., et al. (2005). Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nature Biotechnology, 23(11), 1407–1413.
Zhu, J., Zhou, L., & XingWu, F. (2006). Tracking neural stem cells in patients with brain trauma. The New England Journal of Medicine, 355(22), 2376–2378.
Callera, F., & de Melo, C. M. (2007). Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells’ migration into the injured site. Stem Cells and Development, 16(3), 461–466.
Toso, C., Vallee, J. P., Morel, P., et al. (2008). Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. American Journal of Transplantation, 8, 701–706.
Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., et al. (2010). Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Archives of Neurology, 67(10), 1187–1194.
Yaghoubi, S. S., Jensen, M. C., Satyamurthy, N., et al. (2009). Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nature Clinical Practice. Oncology, 6(1), 53–58.
Amariglio, N., Hirshberg, A., Scheithauer, B. W., et al. (2009). Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Medicine, 6(2), e1000029.
Xie, X., Cao, F., Sheikh, A. Y., et al. (2007). Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning stem cells. Cloning Stem Cells, 9(4), 549–563. Winter.
Acknowledgments
This work was supported in part by Stanford VPUE (WYZ), German Research Foundation (ADE), NIH HL099117 (JCW), and NIH EB009689 (JCW).
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, W.Y., Ebert, A.D., Narula, J. et al. Imaging Cardiac Stem Cell Therapy: Translations to Human Clinical Studies. J. of Cardiovasc. Trans. Res. 4, 514–522 (2011). https://doi.org/10.1007/s12265-011-9281-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-011-9281-3